{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:22:05Z","timestamp":1789662125576,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alberta MS Network Collaboration Seed Grant"},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates | Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atrophy has become a clinically relevant marker of progressive neurodegeneration in multiple sclerosis (MS). To better understand atrophy, mouse models that feature atrophy along with other aspects of MS are needed. The experimental autoimmune encephalomyelitis (EAE) mouse model of MS was used to determine the extent of atrophy in a model of inflammation-associated central nervous system pathology. High-resolution magnetic resonance imaging (MRI) and atlas-based volumetric analysis were performed to measure brain regional volumes in EAE mice. EAE brains were larger at peak clinical disease (days 14\u201316) compared to controls, with affected regions including the cerebellum, hippocampus, and corpus callosum. Following peak clinical disease, EAE mice exhibited significant loss of volume at chronic long-term disease duration (day 66+). Atrophy was identified in both white and grey matter regions including the cerebral cortex, cerebellum, hippocampus, corpus callosum, basal forebrain, midbrain, optic tract, and colliculus. Histological analysis of the atrophied cortex, cerebellum, and hippocampus showed demyelination, and axonal\/neuronal loss. We hypothesize this atrophy could be a result of inflammatory associated neurodegenerative processes, which may also be involved in MS. Using MRI and atlas-based volumetrics, EAE has the potential to be a test bed for treatments aimed at reducing progressive neurological deterioration in MS.<\/jats:p>","DOI":"10.1038\/s41598-019-44682-6","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T10:02:53Z","timestamp":1560247373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis"],"prefix":"10.1038","volume":"9","author":[{"given":"A. Max","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-3224","authenticated-orcid":false,"given":"Nils D.","family":"Forkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Wee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff F.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"44682_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/107385849900500107","volume":"5","author":"BD Trapp","year":"1999","unstructured":"Trapp, B. D., Ransohoff, R. M., Fisher, E. & Rudick, R. A. Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability. The Neuroscientist 5, 48\u201357, https:\/\/doi.org\/10.1177\/107385849900500107 (1999).","journal-title":"The Neuroscientist"},{"key":"44682_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","volume":"10","author":"MA Friese","year":"2014","unstructured":"Friese, M. A., Schattling, B. & Fugger, L. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10, 225\u2013238, https:\/\/doi.org\/10.1038\/nrneurol.2014.37 (2014).","journal-title":"Nat Rev Neurol"},{"key":"44682_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbadis.2010.07.007","volume":"1812","author":"C Stadelmann","year":"2011","unstructured":"Stadelmann, C., Wegner, C. & Br\u00fcck, W. Inflammation, demyelination, and degeneration \u2014 Recent insights from MS pathology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812, 275\u2013282, https:\/\/doi.org\/10.1016\/j.bbadis.2010.07.007 (2011).","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"44682_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-153","volume":"11","author":"HE Hulst","year":"2011","unstructured":"Hulst, H. E. & Geurts, J. J. Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurology 11, 153, https:\/\/doi.org\/10.1186\/1471-2377-11-153 (2011).","journal-title":"BMC Neurology"},{"key":"44682_CR5","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/brain\/awf177","volume":"125","author":"DH Miller","year":"2002","unstructured":"Miller, D. H., Barkhof, F., Frank, J. A., Parker, G. J. & Thompson, A. J. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125, 1676\u20131695 (2002).","journal-title":"Brain"},{"key":"44682_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2741\/1262","volume":"9","author":"R Zivadinov","year":"2004","unstructured":"Zivadinov, R. & Bakshi, R. Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. Front Biosci 9, 647\u2013664 (2004).","journal-title":"Front Biosci"},{"issue":"2","key":"44682_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/brain\/awf025","volume":"125","author":"D. T. Chard","year":"2002","unstructured":"Chard, D. T. et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125 (2002).","journal-title":"Brain"},{"key":"44682_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tins.2016.02.001","volume":"39","author":"C Larochelle","year":"2016","unstructured":"Larochelle, C., Uphaus, T., Prat, A. & Zipp, F. Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology? Trends in Neurosciences 39, 325\u2013339, https:\/\/doi.org\/10.1016\/j.tins.2016.02.001 (2016).","journal-title":"Trends in Neurosciences"},{"key":"44682_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2165\/00023210-200115060-00001","volume":"15","author":"JH Simon","year":"2001","unstructured":"Simon, J. H. Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression. CNS Drugs 15, 427\u2013436 (2001).","journal-title":"CNS Drugs"},{"key":"44682_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1552-6569.2001.tb00022.x","volume":"11","author":"R Bakshi","year":"2001","unstructured":"Bakshi, R., Benedict, R. H. B., Bermel, R. A. & Jacobs, L. Regional Brain Atrophy Is Associated With Physical Disability in Multiple Sclerosis: Semiquantitative Magnetic Resonance Imaging and Relationship to Clinical Findings. Journal of Neuroimaging 11, 129\u2013136, https:\/\/doi.org\/10.1111\/j.1552-6569.2001.tb00022.x (2001).","journal-title":"Journal of Neuroimaging"},{"key":"44682_CR11","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","volume":"66","author":"M Calabrese","year":"2009","unstructured":"Calabrese, M. et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66, 1144\u20131150, https:\/\/doi.org\/10.1001\/archneurol.2009.174 (2009).","journal-title":"Arch Neurol"},{"key":"44682_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1474-4422(06)70349-0","volume":"5","author":"RA Bermel","year":"2006","unstructured":"Bermel, R. A. & Bakshi, R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 5, 158\u2013170, https:\/\/doi.org\/10.1016\/S1474-4422(06)70349-0 (2006).","journal-title":"Lancet Neurol"},{"key":"44682_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp, B. D. et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338, 278\u2013285, https:\/\/doi.org\/10.1056\/NEJM199801293380502 (1998).","journal-title":"N Engl J Med"},{"key":"44682_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0022-510X(01)00576-7","volume":"189","author":"X Lin","year":"2001","unstructured":"Lin, X. & Blumhardt, L. D. Inflammation and atrophy in multiple sclerosis: MRI associations with disease course. Journal of the Neurological Sciences 189, 99\u2013104, https:\/\/doi.org\/10.1016\/S0022-510X(01)00576-7 (2001).","journal-title":"Journal of the Neurological Sciences"},{"key":"44682_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/jnnp.74.11.1551","volume":"74","author":"DT Chard","year":"2003","unstructured":"Chard, D. T. et al. The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. Journal of Neurology, Neurosurgery &amp; Psychiatry 74, 1551\u20131554, https:\/\/doi.org\/10.1136\/jnnp.74.11.1551 (2003).","journal-title":"Journal of Neurology, Neurosurgery &amp; Psychiatry"},{"key":"44682_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer, J. M. et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132, 1175\u20131189, https:\/\/doi.org\/10.1093\/brain\/awp070 (2009).","journal-title":"Brain"},{"key":"44682_CR17","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1523\/JNEUROSCI.1171-15.2016","volume":"36","author":"MJ Bellizzi","year":"2016","unstructured":"Bellizzi, M. J., Geathers, J. S., Allan, K. C. & Gelbard, H. A. Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis. J Neurosci 36, 1336\u20131346, https:\/\/doi.org\/10.1523\/JNEUROSCI.1171-15.2016 (2016).","journal-title":"J Neurosci"},{"key":"44682_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/labinvest.2010.6","volume":"90","author":"MO Ziehn","year":"2010","unstructured":"Ziehn, M. O., Avedisian, A. A., Tiwari-Woodruff, S. & Voskuhl, R. R. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Invest 90, 774\u2013786, https:\/\/doi.org\/10.1038\/labinvest.2010.6 (2010).","journal-title":"Lab Invest"},{"key":"44682_CR19","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1093\/brain\/awm160","volume":"130","author":"D Centonze","year":"2007","unstructured":"Centonze, D. et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain 130, 2543\u20132553, https:\/\/doi.org\/10.1093\/brain\/awm160 (2007).","journal-title":"Brain"},{"key":"44682_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.nbd.2014.11.022","volume":"74","author":"A Gentile","year":"2015","unstructured":"Gentile, A. et al. Dopaminergic dysfunction is associated with IL-1beta-dependent mood alterations in experimental autoimmune encephalomyelitis. Neurobiol Dis 74, 347\u2013358, https:\/\/doi.org\/10.1016\/j.nbd.2014.11.022 (2015).","journal-title":"Neurobiol Dis"},{"key":"44682_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.neuroimage.2009.06.073","volume":"48","author":"A MacKenzie-Graham","year":"2009","unstructured":"MacKenzie-Graham, A. et al. Purkinje cell loss in experimental autoimmune encephalomyelitis. Neuroimage 48, 637\u2013651, https:\/\/doi.org\/10.1016\/j.neuroimage.2009.06.073 (2009).","journal-title":"Neuroimage"},{"key":"44682_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1750-3639.2010.00444.x","volume":"21","author":"M Mangiardi","year":"2011","unstructured":"Mangiardi, M. et al. An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis. Brain Pathology 21, 263\u2013278, https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00444.x (2011).","journal-title":"Brain Pathology"},{"key":"44682_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.nbd.2011.05.021","volume":"43","author":"F Girolamo","year":"2011","unstructured":"Girolamo, F. et al. Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis. Neurobiol Dis 43, 678\u2013689, https:\/\/doi.org\/10.1016\/j.nbd.2011.05.021 (2011).","journal-title":"Neurobiol Dis"},{"key":"44682_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroimage.2011.11.099","volume":"60","author":"A MacKenzie-Graham","year":"2012","unstructured":"MacKenzie-Graham, A. et al. Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging. Neuroimage 60, 95\u2013104, https:\/\/doi.org\/10.1016\/j.neuroimage.2011.11.099 (2012).","journal-title":"Neuroimage"},{"key":"44682_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/glia.22991","volume":"64","author":"KC Clark","year":"2016","unstructured":"Clark, K. C. et al. Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact. Glia 64, 1190\u20131209, https:\/\/doi.org\/10.1002\/glia.22991 (2016).","journal-title":"Glia"},{"key":"44682_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1523\/JNEUROSCI.3659-10.2011","volume":"31","author":"SM Agrawal","year":"2011","unstructured":"Agrawal, S. M., Silva, C., Tourtellotte, W. W. & Yong, V. W. EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci 31, 669\u2013677, https:\/\/doi.org\/10.1523\/JNEUROSCI.3659-10.2011 (2011).","journal-title":"J Neurosci"},{"key":"44682_CR27","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1096\/fj.04-2030fje","volume":"19","author":"A Weaver","year":"2005","unstructured":"Weaver, A. et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1\/Th2 polarization. FASEB J 19, 1668\u20131670, https:\/\/doi.org\/10.1096\/fj.04-2030fje (2005).","journal-title":"FASEB J"},{"key":"44682_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/42.668698","volume":"17","author":"JG Sled","year":"1998","unstructured":"Sled, J. G., Zijdenbos, A. P. & Evans, A. C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17, 87\u201397, https:\/\/doi.org\/10.1109\/42.668698 (1998).","journal-title":"IEEE Trans Med Imaging"},{"key":"44682_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.03.037","volume":"42","author":"AE Dorr","year":"2008","unstructured":"Dorr, A. E., Lerch, J. P., Spring, S., Kabani, N. & Henkelman, R. M. High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl\/6J mice. Neuroimage 42, 60\u201369, https:\/\/doi.org\/10.1016\/j.neuroimage.2008.03.037 (2008).","journal-title":"Neuroimage"},{"key":"44682_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.cmpb.2009.09.002","volume":"98","author":"M Modat","year":"2010","unstructured":"Modat, M. et al. Fast free-form deformation using graphics processing units. Computer methods and programs in biomedicine 98, 278\u2013284, https:\/\/doi.org\/10.1016\/j.cmpb.2009.09.002 (2010).","journal-title":"Computer methods and programs in biomedicine"},{"key":"44682_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ar.1092310411","volume":"231","author":"MJ West","year":"1991","unstructured":"West, M. J., Slomianka, L. & Gundersen, H. J. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. The Anatomical record 231, 482\u2013497, https:\/\/doi.org\/10.1002\/ar.1092310411 (1991).","journal-title":"The Anatomical record"},{"key":"44682_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1759-1961.2012.00032.x","volume":"3","author":"K Marcinko","year":"2012","unstructured":"Marcinko, K., Parsons, T., Lerch, J. P., Sled, J. G. & Sakic, B. Effects of prolonged treatment with memantine in the MRL model of CNS lupus. Clin Exp Neuroimmunol 3, 116\u2013128, https:\/\/doi.org\/10.1111\/j.1759-1961.2012.00032.x (2012).","journal-title":"Clin Exp Neuroimmunol"},{"key":"44682_CR33","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/art.24523","volume":"60","author":"JG Sled","year":"2009","unstructured":"Sled, J. G. et al. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus. Arthritis Rheum 60, 1764\u20131774, https:\/\/doi.org\/10.1002\/art.24523 (2009).","journal-title":"Arthritis Rheum"},{"key":"44682_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/BF02436332","volume":"3","author":"PH Harvey","year":"1988","unstructured":"Harvey, P. H. & Pagel, M. D. The allometric approach to species differences in brain size. Human Evolution 3, 461\u2013472, https:\/\/doi.org\/10.1007\/BF02436332 (1988).","journal-title":"Human Evolution"},{"key":"44682_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/evan.20105","volume":"15","author":"RA Barton","year":"2006","unstructured":"Barton, R. A. Primate brain evolution: Integrating comparative, neurophysiological, and ethological data. Evolutionary Anthropology: Issues, News, and Reviews 15, 224\u2013236, https:\/\/doi.org\/10.1002\/evan.20105 (2006).","journal-title":"Evolutionary Anthropology: Issues, News, and Reviews"},{"key":"44682_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 57, 289\u2013300 (1995).","journal-title":"Journal of the Royal Statistical Society. Series B (Methodological)"},{"key":"44682_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroimage.2015.03.036","volume":"113","author":"LS Cahill","year":"2015","unstructured":"Cahill, L. S. et al. MRI-detectable changes in mouse brain structure induced by voluntary exercise. NeuroImage 113, 175\u2013183, https:\/\/doi.org\/10.1016\/j.neuroimage.2015.03.036 (2015).","journal-title":"NeuroImage"},{"key":"44682_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuroimage.2015.01.027","volume":"109","author":"J Scholz","year":"2015","unstructured":"Scholz, J., Allemang-Grand, R., Dazai, J. & Lerch, J. P. Environmental enrichment is associated with rapid volumetric brain changes in adult mice. NeuroImage 109, 190\u2013198, https:\/\/doi.org\/10.1016\/j.neuroimage.2015.01.027 (2015).","journal-title":"NeuroImage"},{"key":"44682_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuroimage.2013.06.004","volume":"82","author":"MC van Eede","year":"2013","unstructured":"van Eede, M. C., Scholz, J., Chakravarty, M. M., Henkelman, R. M. & Lerch, J. P. Mapping registration sensitivity in MR mouse brain images. NeuroImage 82, 226\u2013236, https:\/\/doi.org\/10.1016\/j.neuroimage.2013.06.004 (2013).","journal-title":"NeuroImage"},{"key":"44682_CR40","doi-asserted-by":"publisher","first-page":"27S","DOI":"10.1111\/j.1552-6569.2004.tb00276.x","volume":"14","author":"R Zivadinov","year":"2004","unstructured":"Zivadinov, R. & Bakshi, R. Central Nervous System Atrophy and Clinical Status in Multiple Sclerosis. Journal of Neuroimaging 14, 27S\u201335S, https:\/\/doi.org\/10.1111\/j.1552-6569.2004.tb00276.x (2004).","journal-title":"Journal of Neuroimaging"},{"key":"44682_CR41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuroimage.2005.10.032","volume":"30","author":"K Morgen","year":"2006","unstructured":"Morgen, K. et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing\u2013remitting MS. NeuroImage 30, 891\u2013898, https:\/\/doi.org\/10.1016\/j.neuroimage.2005.10.032 (2006).","journal-title":"NeuroImage"},{"issue":"8","key":"44682_CR42","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/archneur.64.8.1157","volume":"64","author":"Maria Pia Amato","year":"2007","unstructured":"Amato, M. P. et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol 64 (2007).","journal-title":"Archives of Neurology"},{"key":"44682_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archneurol.2011.674","volume":"69","author":"J Cheriyan","year":"2012","unstructured":"Cheriyan, J., Kim, S., Wolansky, L. J., Cook, S. D. & Cadavid, D. Impact of inflammation on brain volume in multiple sclerosis. Archives of Neurology 69, 82\u201388, https:\/\/doi.org\/10.1001\/archneurol.2011.674 (2012).","journal-title":"Archives of Neurology"},{"key":"44682_CR44","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/1352458514564494","volume":"21","author":"ND Stefano","year":"2015","unstructured":"Stefano, N. D. & Arnold, D. L. Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients. Multiple Sclerosis Journal 21, 675\u2013676, https:\/\/doi.org\/10.1177\/1352458514564494 (2015).","journal-title":"Multiple Sclerosis Journal"},{"key":"44682_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jneuroim.2007.06.016","volume":"189","author":"S Kuerten","year":"2007","unstructured":"Kuerten, S. et al. MP4- and MOG:35\u201355-induced EAE in C57BL\/6 mice differentially targets brain, spinal cord and cerebellum. Journal of Neuroimmunology 189, 31\u201340, https:\/\/doi.org\/10.1016\/j.jneuroim.2007.06.016 (2007).","journal-title":"Journal of Neuroimmunology"},{"key":"44682_CR46","doi-asserted-by":"publisher","first-page":"e32796","DOI":"10.1371\/journal.pone.0032796","volume":"7","author":"H Waiczies","year":"2012","unstructured":"Waiczies, H. et al. Identification of Cellular Infiltrates during Early Stages of Brain Inflammation with Magnetic Resonance Microscopy. Plos One 7, e32796, https:\/\/doi.org\/10.1371\/journal.pone.0032796 (2012).","journal-title":"Plos One"},{"key":"44682_CR47","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.1523\/jneurosci.1859-05.2005","volume":"25","author":"R Aharoni","year":"2005","unstructured":"Aharoni, R., Arnon, R. & Eilam, R. Neurogenesis and Neuroprotection Induced by Peripheral Immunomodulatory Treatment of Experimental Autoimmune Encephalomyelitis. The Journal of Neuroscience 25, 8217\u20138228, https:\/\/doi.org\/10.1523\/jneurosci.1859-05.2005 (2005).","journal-title":"The Journal of Neuroscience"},{"key":"44682_CR48","doi-asserted-by":"publisher","first-page":"13227","DOI":"10.1073\/pnas.1609397113","volume":"113","author":"K Kirschbaum","year":"2016","unstructured":"Kirschbaum, K. et al. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proceedings of the National Academy of Sciences 113, 13227\u201313232, https:\/\/doi.org\/10.1073\/pnas.1609397113 (2016).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"44682_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2014.09.016","volume":"277","author":"BD Clarkson","year":"2014","unstructured":"Clarkson, B. D. et al. Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE. Journal of neuroimmunology 277, 39\u201349, https:\/\/doi.org\/10.1016\/j.jneuroim.2014.09.016 (2014).","journal-title":"Journal of neuroimmunology"},{"key":"44682_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1212\/01.wnl.0000316810.01120.05","volume":"71","author":"R Zivadinov","year":"2008","unstructured":"Zivadinov, R. et al. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology 71, 136\u2013144, https:\/\/doi.org\/10.1212\/01.wnl.0000316810.01120.05 (2008).","journal-title":"Neurology"},{"key":"44682_CR51","first-page":"341","volume":"26","author":"E Pagani","year":"2005","unstructured":"Pagani, E. et al. Regional Brain Atrophy Evolves Differently in Patients with Multiple Sclerosis According to Clinical Phenotype. American Journal of Neuroradiology 26, 341\u2013346 (2005).","journal-title":"American Journal of Neuroradiology"},{"key":"44682_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2009.02.322","volume":"282","author":"M Battaglini","year":"2009","unstructured":"Battaglini, M. et al. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences 282, 55\u201360, https:\/\/doi.org\/10.1016\/j.jns.2009.02.322 (2009).","journal-title":"Journal of the Neurological Sciences"},{"key":"44682_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.10.006","volume":"45","author":"K Bendfeldt","year":"2009","unstructured":"Bendfeldt, K. et al. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis \u2014 A longitudinal voxel-based morphometry study. NeuroImage 45, 60\u201367, https:\/\/doi.org\/10.1016\/j.neuroimage.2008.10.006 (2009).","journal-title":"NeuroImage"},{"key":"44682_CR54","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/archneurol.2008.562","volume":"66","author":"J Sepulcre","year":"2009","unstructured":"Sepulcre, J. et al. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: Evidence from voxel-based analysis of t1 lesions in the visual pathway. Archives of Neurology 66, 173\u2013179, https:\/\/doi.org\/10.1001\/archneurol.2008.562 (2009).","journal-title":"Archives of Neurology"},{"issue":"1-2","key":"44682_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2008.12.035","volume":"282","author":"Guozhi Tao","year":"2009","unstructured":"Tao, G. et al. Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry. J Neurol Sci 282 (2009).","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"44682_CR56","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1177\/1352458510374893","volume":"16","author":"VM Anderson","year":"2010","unstructured":"Anderson, V. M. et al. Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. Mult Scler 16 (2010).","journal-title":"Multiple Sclerosis Journal"},{"issue":"4","key":"44682_CR57","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/brain\/awn030","volume":"131","author":"N. L. Sicotte","year":"2008","unstructured":"Sicotte, N. L. et al. Regional hippocampal atrophy in multiple sclerosis. Brain 131 (2008).","journal-title":"Brain"},{"key":"44682_CR58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/jon.12124","volume":"25","author":"EC Klawiter","year":"2015","unstructured":"Klawiter, E. C. et al. Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis. Journal of neuroimaging: official journal of the American Society of Neuroimaging 25, 62\u201367, https:\/\/doi.org\/10.1111\/jon.12124 (2015).","journal-title":"Journal of neuroimaging: official journal of the American Society of Neuroimaging"},{"key":"44682_CR59","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1177\/1352458511403528","volume":"17","author":"VM Anderson","year":"2011","unstructured":"Anderson, V. M. et al. A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis. Multiple Sclerosis (Houndmills, Basingstoke, England) 17, 1079\u20131087, https:\/\/doi.org\/10.1177\/1352458511403528 (2011).","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"key":"44682_CR60","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/wnl.53.8.1698","volume":"53","author":"RA Rudick","year":"1999","unstructured":"Rudick, R. A. et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 53, 1698, https:\/\/doi.org\/10.1212\/wnl.53.8.1698 (1999).","journal-title":"Neurology"},{"key":"44682_CR61","doi-asserted-by":"publisher","unstructured":"Sun, J. -J., Ren, Q. -G., Xu, L. & Zhang, Z. -J. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice. Scientific Reports 5, 14235, https:\/\/doi.org\/10.1038\/srep14235, https:\/\/www.nature.com\/articles\/srep14235-supplementary-information (2015).","DOI":"10.1038\/srep14235"},{"key":"44682_CR62","doi-asserted-by":"publisher","first-page":"20101","DOI":"10.1073\/pnas.1209934109","volume":"109","author":"KA Rahn","year":"2012","unstructured":"Rahn, K. A. et al. Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 109, 20101\u201320106, https:\/\/doi.org\/10.1073\/pnas.1209934109 (2012).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"44682_CR63","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/NEN.0b013e31826ac110","volume":"71","author":"M Errede","year":"2012","unstructured":"Errede, M. et al. Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis. Journal of Neuropathology & Experimental Neurology 71, 840\u2013854, https:\/\/doi.org\/10.1097\/NEN.0b013e31826ac110 (2012).","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"44682_CR64","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/cne.21307","volume":"502","author":"DA Brown","year":"2007","unstructured":"Brown, D. A. & Sawchenko, P. E. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. Journal of Comparative Neurology 502, 236\u2013260, https:\/\/doi.org\/10.1002\/cne.21307 (2007).","journal-title":"Journal of Comparative Neurology"},{"key":"44682_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nbd.2007.06.011","volume":"28","author":"S-W Sun","year":"2007","unstructured":"Sun, S.-W., Liang, H.-F., Schmidt, R. E., Cross, A. H. & Song, S.-K. Selective Vulnerability of Cerebral White Matter in a Murine Model of Multiple Sclerosis Detected Using Diffusion Tensor Imaging. Neurobiology of disease 28, 30\u201338, https:\/\/doi.org\/10.1016\/j.nbd.2007.06.011 (2007).","journal-title":"Neurobiology of disease"},{"key":"44682_CR66","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.0500073102","volume":"102","author":"G D\u2019Intino","year":"2005","unstructured":"D\u2019Intino, G. et al. Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats. Proceedings of the National Academy of Sciences of the United States of America 102, 3070\u20133075, https:\/\/doi.org\/10.1073\/pnas.0500073102 (2005).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"44682_CR67","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti, C. et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Annals of Neurology 47, 707\u2013717, https:\/\/doi.org\/10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q (2000).","journal-title":"Annals of Neurology"},{"key":"44682_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/B978-0-444-52001-2.00002-9","volume":"122","author":"A Kutzelnigg","year":"2014","unstructured":"Kutzelnigg, A. & Lassmann, H. Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handbook of Clinical Neurology 122, 15\u201358, https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00002-9 (2014).","journal-title":"Handbook of Clinical Neurology"},{"key":"44682_CR69","doi-asserted-by":"publisher","first-page":"v3","DOI":"10.1007\/s00415-005-5002-7","volume":"252","author":"W Br\u00fcck","year":"2005","unstructured":"Br\u00fcck, W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. Journal of Neurology 252, v3\u2013v9, https:\/\/doi.org\/10.1007\/s00415-005-5002-7 (2005).","journal-title":"Journal of Neurology"},{"key":"44682_CR70","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrd.2017.115","volume":"16","author":"JR Plemel","year":"2017","unstructured":"Plemel, J. R., Liu, W.-Q. & Yong, V. W. Remyelination therapies: a new direction and challenge in multiple sclerosis. Nature Reviews Drug Discovery 16, 617, https:\/\/doi.org\/10.1038\/nrd.2017.115 (2017).","journal-title":"Nature Reviews Drug Discovery"},{"issue":"10","key":"44682_CR71","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1177\/1352458514533230","volume":"20","author":"Jorge Correale","year":"2014","unstructured":"Correale, J. The role of microglial activation in disease progression. Mult Scler 20, https:\/\/doi.org\/10.1177\/1352458514533230 (2014).","journal-title":"Multiple Sclerosis Journal"},{"key":"44682_CR72","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fneur.2015.00180","volume":"6","author":"J Correale","year":"2015","unstructured":"Correale, J. & Farez, M. F. The Role of Astrocytes in Multiple Sclerosis Progression. Frontiers in Neurology 6, 180, https:\/\/doi.org\/10.3389\/fneur.2015.00180 (2015).","journal-title":"Frontiers in Neurology"},{"key":"44682_CR73","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.12688\/f1000research.11839.1","volume":"6","author":"RA Desai","year":"2017","unstructured":"Desai, R. A. & Smith, K. J. Experimental autoimmune encephalomyelitis from a tissue energy perspective. F1000 Research 6, 1973, https:\/\/doi.org\/10.12688\/f1000research.11839.1 (2017).","journal-title":"F1000 Research"},{"key":"44682_CR74","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.neuroimage.2014.07.017","volume":"101","author":"RD Spence","year":"2014","unstructured":"Spence, R. D. et al. Bringing CLARITY to gray matter atrophy. Neuroimage 101, 625\u2013632, https:\/\/doi.org\/10.1016\/j.neuroimage.2014.07.017 (2014).","journal-title":"Neuroimage"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44682-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44682-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44682-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:23:36Z","timestamp":1671272616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44682-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44682"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44682-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"8 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8488"}}